Douglas W. Blayney

Publication Details

  • The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy.

    Kleinman L, Benjamin K, Viswanathan H, Mattera MS, Bosserman L, Blayney DW, Revicki DA. Qual Life Res. 2012; 21 (7): 1255-66

    To develop a patient-reported outcome instrument for measuring anemia symptoms and their impact in patients with chemotherapy-induced anemia (CIA).

    PubMedID: 21987032

Stanford Medicine Resources:

Footer Links: